Product Images Ranolazine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Ranolazine NDC 68180-354 by Lupin Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Ranolazine - c20f8d18 1ed7 4f03 9df2 b0fbf38bb35c 01

Ranolazine - c20f8d18 1ed7 4f03 9df2 b0fbf38bb35c 01

NDC 68180-354-07RANOLAZINE EXTENDED-RELEASE TABLETS 500 mgRx only Container Label: Bottle of 60 Tablets - c20f8d18 1ed7 4f03 9df2 b0fbf38bb35c 02

NDC 68180-354-07RANOLAZINE EXTENDED-RELEASE TABLETS 500 mgRx only								Container Label: Bottle of 60 Tablets - c20f8d18 1ed7 4f03 9df2 b0fbf38bb35c 02

Ranolazine is a medication that comes in the form of extended-release tablets, contained in a bottle of 60 tablets. Each tablet is coated with a film and contains 500 mg of the medication, Ranolazine. It is important to swallow the tablets whole and not crush, break, or chew them. The complete dosing instructions are in the accompanying prescribing information. The tablets should be stored around 25°C (77°F), with excursions permitted to 15° to 30°C (58°to 86°F) as per USP Controlled Room Temperature. The product is manufactured by Lupin Limited, Goa, India, for Lupin Pharmaceuticals, Inc. located in Baltimore, Maryland, 21202, United States.*

NDC 68180-355-07RANOLAZINE EXTENDED-RELEASE TABLETS 1000 mgRx only Container Label: Bottle of 60 Tablets - c20f8d18 1ed7 4f03 9df2 b0fbf38bb35c 03

NDC 68180-355-07RANOLAZINE EXTENDED-RELEASE TABLETS 1000 mgRx only								Container Label: Bottle of 60 Tablets - c20f8d18 1ed7 4f03 9df2 b0fbf38bb35c 03

This is a description of a prescription medication manufactured for Lupin Pharmaceuticals, Inc., containing 1000 mg of ranolazine per film-coated extended-release tablet. The dosage and use instructions are provided in accompanying prescribing information. The tablets should be swallowed whole and should not be crushed, broken, or chewed. The medication should be stored at 25°C (77°F) with permitted excursions between 15° to 30°C (59° to 86°F) and should be kept in USP Controlled Room Temperature. The tablet's manufacture is also provided, which is Lupin Limited, located in Goa, 403 722 INDIA. The code number is GO/DRUGS/654, and 60 tablets are included in the prescription.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.